CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenue
Diagnostic testing service	$ 9,875	$ 120,488	$ 33,999	$ 289,718
Product sales	0	205,590	0	219,030
Total Revenue	9,875	326,078	33,999	508,748
Cost of Revenue
Diagnostic testing service	0	2,356	0	49,955
Product sales	0	219,804	0	238,669
Total Cost of Revenue	0	222,160	0	288,624
Gross Profit	9,875	103,918	33,999	220,124
Selling expenses	223,385	319,390	461,223	591,965
Research and development expenses	510,767	189,955	933,270	410,147
General and administrative expenses	2,462,256	2,177,920	4,236,964	3,742,792
Total operating expenses	3,196,408	2,687,265	5,631,457	4,744,904
Operating Loss	(3,186,533)	(2,583,347)	(5,597,458)	(4,524,780)
Interest income	0	0	143	0
Interest expense	1,443	352	2,192	359
Loss before Income Taxes	(3,187,976)	(2,583,699)	(5,599,507)	(4,525,139)
Income Taxes	0	0	0	0
Net Loss	$ (3,187,976)	$ (2,583,699)	$ (5,599,507)	$ (4,525,139)
Loss per common share - basic and diluted (in dollars per share)	$ (0.23)	$ (0.17)	$ (0.24)	$ (0.32)
Weighted average shares outstanding, basic & diluted (in shares)	24,430,346	14,808,728	23,515,576	14,120,962